or Try an Advanced Search...

    Technical Analysis for BLUE - bluebird bio, Inc.

    Grade Last Price % Change Price Change
    F 0.47 0.43% 0.00
    BLUE closed up 0.43 percent on Friday, November 1, 2024, on 55 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Nov 5
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BLUE trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Doji - Bullish? Reversal 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 0.43%
    Bollinger Band Squeeze Range Contraction 0.43%
    Down 3 Days in a Row Weakness 0.43%
    Bollinger Band Squeeze Range Contraction -4.66%
    Older End-of-Day Signals for BLUE ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 17 hours ago
    Fell Below Previous Day's Low about 17 hours ago
    Possible NR7 about 18 hours ago
    Possible Inside Day about 18 hours ago
    Up 2% about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BLUE Chart by TradingView
    Basic chart:

    Profile

    bluebird bio, Inc. Description

    bluebird bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases. Its product candidates include Lenti-D to treat patients with childhood cerebral adrenoleukodystrophy (ALD), a hereditary neurological disorder, as well as for the treatment of adult cerebral ALD; and CAR T cells products for treating oncology diseases. The company's product candidates also comprise LentiGlobin vector for the treatment of ß-thalassemia, a hereditary blood disorder; and sickle cell diseases. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Rare Diseases Medical Genetics Dystrophy Human Diseases Summit Childhood Genetic Genealogy Sickle Cell Disease Thalassemia Iglo Oncology Diseases

    Is BLUE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies
    Oct 11 Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy
    Oct 10 7 children given bluebird's Skysona developed blood cancer: study
    Oct 10 Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials
    Oct 9 Top 10 most shorted stocks on Wall Street
    Sep 27 Bluebird: Q2 Earnings Snapshot
    Sep 27 bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing
    Sep 26 bluebird bio: Scientific Success And Financial Success, And The Gap Between
    Sep 24 Gene Therapy-Focused Bluebird Bio Restructures, Cuts Is Workforce By 25%, Seeks To Breakeven Next Year
    Sep 24 bluebird bio to cut workforce by about 25%
    See more BLUE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.53
    52 Week Low 0.4529
    Average Volume 6,310,422
    200-Day Moving Average 0.95
    50-Day Moving Average 0.53
    20-Day Moving Average 0.49
    10-Day Moving Average 0.49
    Average True Range 0.03
    RSI (14) 39.76
    ADX 13.15
    +DI 13.77
    -DI 19.24
    Chandelier Exit (Long, 3 ATRs) 0.47
    Chandelier Exit (Short, 3 ATRs) 0.56
    Upper Bollinger Bands 0.52
    Lower Bollinger Band 0.47
    Percent B (%b) 0.02
    BandWidth 11.09
    MACD Line -0.02
    MACD Signal Line -0.02
    MACD Histogram 0.0021
    Fundamentals Value
    Market Cap 89.82 Million
    Num Shares 193 Million
    EPS -0.63
    Price-to-Earnings (P/E) Ratio -0.74
    Price-to-Sales 9.32
    Price-to-Book 0.89
    PEG Ratio 0.32
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.51
    Resistance 3 (R3) 0.51 0.50 0.50
    Resistance 2 (R2) 0.50 0.49 0.50 0.50
    Resistance 1 (R1) 0.48 0.48 0.48 0.48 0.49
    Pivot Point 0.47 0.47 0.47 0.47 0.47
    Support 1 (S1) 0.46 0.46 0.45 0.45 0.44
    Support 2 (S2) 0.44 0.45 0.44 0.44
    Support 3 (S3) 0.43 0.44 0.43
    Support 4 (S4) 0.43